Nestle invests $200 million more in Aimmune after peanut allergy drug approval
Aimmune Therapeutics Inc said on Wednesday the health science arm of Nestle SA will invest an ...
Read moreAimmune Therapeutics Inc said on Wednesday the health science arm of Nestle SA will invest an ...
Read more